Stockreport

GH Research Reports Full Year 2023 Financial Results and Provides Business Updates

GH Research PLC - Ordinary Shares  (GHRS) 
PDF Phase 2b clinical trial of GH001 in patients with treatment-resistant depression on track for expected completion of double-blind phase in Q3 2024Phase 2a clinical trial [Read more]